Brendan Antiochos
Overview
Explore the profile of Brendan Antiochos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
563
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murillo-Chavez F, Antiochos B
Rheumatol Adv Pract
. 2024 Oct;
8(4):rkae116.
PMID: 39411287
Objectives: Differentiating VEXAS syndrome from cases of canonical forms of primary vasculitis remains a significant clinical challenge, particularly for ANCA-associated vasculitis (AAV). We reviewed the clinical features of VEXAS as...
2.
Thomas M, Kim S, Curran A, Smith B, Antiochos B, Na C, et al.
Philos Trans R Soc Lond B Biol Sci
. 2023 Oct;
378(1890):20220477.
PMID: 37778379
Peptidylarginine deiminase IV (PAD4) post-translationally converts arginine residues in proteins to citrullines and is implicated in playing a central role in the pathogenesis of several diseases. Although PAD4 was historically...
3.
Crawford J, Wang H, Trejo-Zambrano D, Cimbro R, Talbot Jr C, Thomas M, et al.
JCI Insight
. 2023 Sep;
8(20.
PMID: 37733447
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with a dramatic sex bias, affecting 9 times more women than men. Activation of Toll-like receptor 7 (TLR7) by self-RNA is...
4.
Antiochos B, Casciola-Rosen L
Front Med (Lausanne)
. 2023 May;
10:1165225.
PMID: 37228405
Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature...
5.
6.
Xu L, Kant S, Aqeel F, Antiochos B, Li C, Snopkowski C, et al.
J Nephrol
. 2022 Sep;
36(4):1075-1077.
PMID: 36083534
No abstract available.
7.
Gomez-Banuelos E, Wahadat M, Li J, Paz M, Antiochos B, Celia A, et al.
JCI Insight
. 2022 Aug;
7(19).
PMID: 36040804
The origin and mechanisms of autoantigen generation in systemic lupus erythematosus (SLE) are poorly understood. Here, we identified SLE neutrophils activated in vivo by IFN as a prominent source of...
8.
Sheth S, Solomon A, Antiochos B, Evans N, Ratchford E
Vasc Med
. 2022 Jul;
27(5):521-524.
PMID: 35879907
No abstract available.
9.
Churilla B, Aqeel F, Azar A, Antiochos B, Seo P, Hellmann D, et al.
Kidney Int
. 2022 Jul;
102(2):444-445.
PMID: 35870815
No abstract available.
10.
Antiochos B, Trejo-Zambrano D, Fenaroli P, Rosenberg A, Baer A, Garg A, et al.
Elife
. 2022 May;
11.
PMID: 35608258
Background: Nucleic acid binding proteins are frequently targeted as autoantigens in systemic lupus erythematosus (SLE) and other interferon (IFN)-linked rheumatic diseases. The AIM-like receptors (ALRs) are IFN-inducible innate sensors that...